Monarch Partners Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-6,509
Closed -$560K – 181
2022
Q1
$560K Sell
6,509
-48,247
-88% -$3.96M 0.13% 147
2021
Q4
$4.47M Sell
54,756
-12,627
-19% -$923K 0.91% 36
2021
Q3
$4.48M Sell
67,383
-40,003
-37% -$2.84M 0.65% 65
2021
Q2
$7.19M Buy
+107,386
New +$6.66M 1.03% 36

Other funds holding THC

Monarch Partners Asset Management's THC Position: Q2 2022 in Review

Monarch Partners Asset Management sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 6,509 shares — an estimated $560K sold.

Monarch Partners Asset Management first reported a position in THC in Q2 2021 and held it in 4 quarters. The position peaked at $7.19M in Q2 2021. 371 funds tracked by Wall St. Rank hold THC as of Q2 2022.

  • Monarch Partners Asset Management reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
  • Monarch Partners Asset Management sold 6,509 Tenet Healthcare shares in Q2 2022, an estimated $560K.
  • Monarch Partners Asset Management first reported a position in Tenet Healthcare in Q2 2021 and held it in 4 quarters.
  • Monarch Partners Asset Management's Tenet Healthcare position peaked at $7.19M in Q2 2021.
  • 371 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Monarch Partners Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.